This patent covers the use of HGF for stimulation of hematopoietic stem cell proliferation, as well as differentiation along the erythroid lineage. This patent may be useful for the treatment of anemia, as well as post hematopoietic stem cell ablation patients.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.